N
This company provides a rapid, non-invasive diagnostic platform for identifying airborne respiratory pathogens directly from exhaled air. The system uses proprietary electrostatic precipitation followed by isothermal molecular amplification (LAMP) to detect up to 12 pathogens simultaneously within 20 minutes. This technology streamlines patient pathways and supports antimicrobial stewardship by offering high-performance diagnostics in various clinical settings.
Updated 2 months ago
Funding
Funding not disclosed
Funding rounds are not available yet.
Founders
Founder details are not available yet.
Product
Features
- Nawu diagnostics develops a point-of-care system for rapid identification of respiratory pathogens directly from ambient air aerosols. The platform uses proprietary electrostatic precipitation followed by isothermal molecular amplification (LAMP) to detect up to 12 pathogens simultaneously within 20 minutes. This autonomous, battery-operated device streamlines patient pathways and supports antimicrobial stewardship by providing timely, high-performance diagnostics in various clinical settings.